Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-885-0 | CAS number: 100-74-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Bacterial reverse mutation assay (Ames test)
An Ames test with S. typhimurium TA 1535, TA 1537, TA 98 and TA 100 or E. coli WP2 uvr A with and without metabolic activation was evaluated in an OECD SIDS report (Key study, K2). Following test concentrations were applied: 0, 313, 625, 1250, 2500 and 5000 µg/plate (3 plates/dose; 2 replicates), the vehicle was distilled water. Solvent control and positive controls were run and judged valid. Toxicity (growth inhibition) was not observed in any strain, with or without S9 mix. No increase of revertants was observed at with or without S9 mix.
Mammalian chromosome aberration test:
A chromosome aberration test was performed with N-ethylmorpholine (NEM) with the mammalian cell line CHL/IU (Chinese hamster lung) with and without metabolic activation (key study, K2). Following doses were tested in duplicate: 0, 150, 300, 600 and 1200 µg/m for 6 hours (with and without S9) or 24 hours (without S9). With the 6 hr short-term treatment, chromosomal aberrations or polyploidy were not induced, with or without S9 mix. Moreover, chromosomal aberrations or polyploidy were not induced after the 24 hr continuous treatment without S9 mix. Cytotoxicity was not observed for 6 hr short-term treatment, with or without S9 mix, however it was observed at 1200 ug/mL for 24 hr continuous treatment without S9 mix. There were no problems observed in the control groups.
Mammalian cell gene mutation assay (TK locus in L5178Y):
Mutagenicity of N-Ethyl morpholine was studied in TK locus in L5178Y mouse lymphoma cells with and without metabolic activation. The following test concentrations, water being the vehicle, were used: Without metabolic activation: 78, 2500, 3000, 4000 and 5000 nL/mL; With metabolic activation: 78, 156, 1250, 2000 and 2500 nL/mL (in triplicate). Solvent control, negative control and positive controls were run and judged valid. The test material did not induce significant changes in the mutant frequency at the TK locus in L5178Y mouse lymphoma cells. Cytotoxicity was observed in concentrations > 1250 nL/mL (with activation) and > 5000 nL/mL (without activation). The study was rated Key K2.
Mammalian cell gene mutation assay (L5178Y TK+/-):
In addition to the cell transformation assay with BALB/3T3, Conaway CC, Myhr BC, Rundell JO, Brusick DJ (1982) also performed a cell gene mutation assay with L5178. Five dose levels (doses were selected for assays which insured a 50-90% reduction in growth at the highest concentration) were tested. Solvent control and positive controls were run and judged valid. No cytoxicity was observed. Based on mutant frequency N-methyl morpholine was clearly not mutagenic in the L5178Y TK+/- mouse lymphoma assay. This result from an analogue substance is in support to the earlier result in a study by Mhyr B, 1980. Therefore the study was rated a supporting study.
Mammalian cell transformation assay (BALB/3T3):
Conaway CC, Myhr BC, Rundell JO, Brusick DJ (1982) tested mutagenicity of N-Ethyl morpholine with BALB/3T3 mouse fibroblasts with metabolic activation. Five doses which resulted in 50-100% cell survival were tested. Solvent control, and positive controls were run and were valid, however no negative control was used. No numeric result is available. The study concluded that the result was negative, i.e. the substance is not mutagenic. The study was rated K2 and supporting.
Justification for selection of genetic toxicity endpoint
Well-documented study, equivalent to an OECD guideline, study with mammalian cells, supported by reliable bacterial reverse mutation test and chromosome aberration tests.
Short description of key information:
Genetic toxicity in vitro:
Three reliable key in vitro genetic toxicity studies with NEM are available.
N-Ethyl morpholine has been assessed in a bacterial reverse mutation test (Ames, according to OECD guideline 471) and is considered not mutagenic.
In a chromosome aberration test performed according to OECD guideline 473 , N-ethylmorpholine is considered not clastogenicwith or without metabolic activation.
In a mammalian cell gene mutation assay with L5178Y TK+/- mouse lymphoma following no specific guideline N-methyl morpholine was clearly not mutagenic with and without metabolic activation.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the available data and according to the criteria of the CLP Regulation (EC) 1272/2008, NEM should not be classified for mutagenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.